V
Vericel Corp D
D
VCEL
43.470
USD
-0.92
(-2.07%)
مغلق
حجم التداول
23,563
الربح لكل سهم
0
العائد الربحي
-
P/E
217
حجم السوق
2,179,406,008
الأخبار المقالات
العنوان: Vericel Corp
القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.